Bend Research, part of Capsugel’s Dosage Form Solutions business unit, has added Capsugel’s Xcelodose powder-filling technology. The microdosing technology will help develop Bend Research’s recently announced Rapid Advancement of Preclinical Compounds initiative.
The Xcelodose 600S powder microdosing system enables the dispensing of dose weights as low as 100 micrograms, without excipients or bulking agents. The technology is used to prepare products for clinical trials and small-scale production. The Xcelodose technology will have specific applications in Bend Research’s oral and inhalation product development.
